XML 83 R51.htm IDEA: XBRL DOCUMENT v3.25.0.1
Equity (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangements [Abstract]  
Schedule of Share-Based Compensation
Share-based compensationDecember 31, 2024December 31, 2023
Option Expense$896 $3,035 
DSU Expense511 397 
RSU Expense6,049 7,288 
Total share-based compensation for continuing operations (per statement of loss)$7,456 $10,720 
Discontinued operations— 239 
Total share-based compensation (per statement of equity)$7,456 $10,959 
20.     Equity (cont'd):
Schedule of Number and Weighted Average Exercise Prices of Share Options
As at December 31, options outstanding from the consolidated share option plan were as follows:
BalanceOptions for common sharesWeighted average exercise price
At January 1, 20234,807,620 $9.19 
Options exercised(152,120)2.25 
Options forfeited(263,253)10.39 
Options expired(2,025)1.36 
At December 31, 20234,390,222 8.65 
Options exercised(154,509)1.89 
Options forfeited(152,282)8.73 
Options expired(320,411)9.50 
At December 31, 20243,763,020 $8.85 
Schedule of Number and Weighted Average Remaining Contractual Life of Outstanding Share Options
The following table summarizes information about the Corporation’s share options outstanding as at December 31, 2024:
Options outstandingOptions exercisable
NumberWeighted average
remaining
contractual life
Weighted
average
exercise
NumberWeighted
average
Range of exercise priceoutstanding(years)priceexercisableexercise price
$1.86 - $3.06
812,156 1.0$2.77 812,156 $2.77 
$3.35 - $5.17
392,397 0.83.65 386,186 3.62 
$6.51 - $10.64
1,782,164 3.19.41 1,532,083 9.52 
$11.88 - $26.13
776,303 3.016.55 776,303 16.55 
3,763,020 2.4$8.85 3,506,728 $8.86 
Schedule of Range of Exercise Prices of Outstanding Share Options
The following table summarizes information about the Corporation’s share options outstanding as at December 31, 2024:
Options outstandingOptions exercisable
NumberWeighted average
remaining
contractual life
Weighted
average
exercise
NumberWeighted
average
Range of exercise priceoutstanding(years)priceexercisableexercise price
$1.86 - $3.06
812,156 1.0$2.77 812,156 $2.77 
$3.35 - $5.17
392,397 0.83.65 386,186 3.62 
$6.51 - $10.64
1,782,164 3.19.41 1,532,083 9.52 
$11.88 - $26.13
776,303 3.016.55 776,303 16.55 
3,763,020 2.4$8.85 3,506,728 $8.86 
Schedule of Number and Weighted Average Exercise Prices of Other Equity Instruments
BalanceDSUs for common shares
At January 1, 2023709,680 
DSUs granted93,188 
DSUs exercised(65,499)
At December 31, 2023737,369 
DSUs granted252,299 
DSUs exercised— 
At December 31, 2024989,668 
BalanceRSUs for common shares
At January 1, 20231,002,080 
RSUs granted2,996,387 
RSUs exercised(279,668)
RSUs forfeited(577,353)
At December 31, 20233,141,446 
RSUs granted3,151,939 
RSUs exercised(642,850)
RSUs forfeited(1,058,440)
At December 31, 20244,592,095